Open access
Jul 2026
SARS-CoV-2 RBD fusion ameliorates enhanced disease induced by RSV G CCD mRNA vaccine in BALB/c mice
Findings provide proof of concept that heterologous antigen fusion can reshape CCD-associated immunopathology in a BALB/c RSV challenge model and significantly attenuate CCD-induced immunopathology.
Yufang Sun, Ying Xie, Lian Liu et al.
· npj Vaccines · 0 citations